Amount Raised
$150 Million
Round Type
Post-IPO Equity
BostonBiotechnologyHealthcareInvestors
Description
On September 29, 2026, Pyxis Oncology, Inc. entered into an underwriting agreement for an underwritten public offering. The offering includes approximately 36 million shares of common stock and pre-funded warrants for additional shares. The transaction is set to close on October 1, 2026
Quick answer
Pyxis Oncology, Inc. raised $150 Million in a Post-IPO Equity round, dated October 1, 2026. Investors: Wells Fargo Securities, LLC, Guggenheim Securities, LLC and Leerink Partners LLC. Pyxis Oncology, Inc. is based in Boston, Massachusetts, United States.
- How much did Pyxis Oncology, Inc. raise?
- Pyxis Oncology, Inc. raised $150 Million in a Post-IPO Equity round on October 1, 2026.
- Who invested in Pyxis Oncology, Inc?
- Wells Fargo Securities, LLC, Guggenheim Securities, LLC and Leerink Partners LLC are named as investors in this round.
- What does Pyxis Oncology, Inc. do?
- Pyxis Oncology is transforming the lives of patients with cancer by advancing our differentiated portfolio of biologics that specifically target tumor cells and overcome immune suppression.
- Where is Pyxis Oncology, Inc. based and how big is it?
- Pyxis Oncology, Inc. is based in Boston, Massachusetts, United States. Fundz records about 44 employees.
- Who are the decision-makers at Pyxis Oncology, Inc?
- Fundz holds 1 contact at Pyxis Oncology, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Pyxis Oncology, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Annovis Bio raised $21M (Post-IPO Equity) on November 5, 2026.
- Equinox raised $1B on November 2, 2026.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
- Araceli Biosciences raised $4.5M (Seed) on October 20, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
Who to call at Pyxis Oncology, Inc., and when
A new round usually means Pyxis Oncology, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pyxis Oncology, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pyxis Oncology, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pyxis Oncology, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pyxis Oncology, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pyxis Oncology, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.